New Study Finds Common Drugs May Not Work for Some People
New Study Finds Common Drugs May Not Work for Some People
A new study highlights that the common 'one-size-fits-all' approach to medicine is being challenged by the field of pharmacogenomics.
This study explores how our unique DNA influences how our bodies process drugs.
Some people are 'ultrametabolizers,' breaking down medication too quickly for it to help, while others may experience toxic side effects because they process it too slowly.
Historically, clinical trials have focused on a 'population-average' model, often ignoring ethnic diversity in genetics.
This has led to a frustrating 'trial and error' process for patients seeking treatment for conditions like depression.
The shift toward precision medicine aims to solve this by using predictive testing to identify the best drugs for an individual before a prescription is written.
Although 90% of people carry genetic markers that affect drug response, widespread testing remains uncommon due to logistical and economic hurdles.
